Welcome to LookChem.com Sign In|Join Free

CAS

  • or

219921-93-4

Post Buying Request

219921-93-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

219921-93-4 Usage

General Description

(R)-3-methyl-1-(2-(1-pieridinyl)phenyl)-butylamine is a chemical compound with the molecular formula C18H25N. It is an amine compound with a butylamine chain and a phenyl group containing a pyridine ring. The compound is chiral, with the (R) enantiomer being the active form. It is used in the synthesis of pharmaceuticals and other organic compounds. It may also have biological activity and potential applications in drug development and research.

Check Digit Verification of cas no

The CAS Registry Mumber 219921-93-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,9,9,2 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 219921-93:
(8*2)+(7*1)+(6*9)+(5*9)+(4*2)+(3*1)+(2*9)+(1*3)=154
154 % 10 = 4
So 219921-93-4 is a valid CAS Registry Number.

219921-93-4Relevant articles and documents

Reversal diastereoselectivity between the organomagnesium and organolithium reagents on Chiral N-tert-butylsulfinylaldimines for the preparation of chiral amines

Rajendiran, Chinnapillai,Nagarajan, Periyandi,Naidu,Dubey

, p. 2936 - 2942 (2014/11/08)

The asymmetric synthesis of both the enantiomer of chiral amines from the single chiral source of N-tert-butylsulfinylaldimines (3) by simply changing the organometallic reagents through diastereoselective addition. An efficient enantioselective synthesis of chiral amines including (S)-3-methyl-1-(2- piperidin-1-yl-phenyl)butyl amine (6a), a key intermediate to prepare antidiabetic drug repaglinide (1), is reported.

Process for the preparation of substantially optically pure Repaglinide and precursors thereof

-

Page/Page column 13, (2010/05/13)

The invention relates to a process for preparing substantially optically pure Repaglinide and pharmaceutically acceptable salts, solvates and esters thereof, as well as precursors therefore.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 219921-93-4